Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-7113b Phase I single-dose PK and food-effect study in healthy male Japanese subjects
jRCT2080222121Phase 1
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of hydromorphone in pain (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Safety and tolerability of DS-7113b after a single oral dose, Pharmacokinetics of DS-7113b after a single oral dose and 1 more.
02
Drugs
hydromorphone
03
Conditions
pain
Beyond the preview
Go deeper on jRCT2080222121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222121.